Morrisville, NC, United States of America

Tyson D Bowen

This inventor holds 15 USPTO granted patents and 14 published patent applications and 3 EPO patents. Top assignee: Lifeedit Therapeutics, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tyson D Bowen. Retrieved from https://idiyas.com/inventor/tyson-d-bowen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 14)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 12)

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 4(Granted Patents)

Company Filing History:

15 out of 18

Lifeedit Therapeutics, Inc.

patents

Years Active: 2021-2026

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12680096 - RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (2026-07-14),

2. 12655426 - Polypeptides useful for gene editing and methods of use (2026-06-16),

3. 12624369 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2026-05-12),

4. 12398384 - DNA modifying enzymes and active fragments and variants thereof and methods of use (2025-08-26),

5. 12338455 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2025-06-24),

6. 12252718 - DNA modifying enzymes and active fragments and variants thereof and methods of use (2025-03-18),

7. 12252706 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2025-03-18),

8. 12188062 - DNA modifying enzymes and active fragments and variants thereof and methods of use (2025-01-07),

9. 12188061 - Nucleic acid molecules encoding DNA modifying enzymes and active fragments and variants thereof and compositions comprising the same (2025-01-07),

10. 12188018 - Polypeptides useful for gene editing and methods of use (2025-01-07),

11. 11981940 - DNA modifying enzymes and active fragments and variants thereof and methods of use (2024-05-14),

12. 11981916 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2024-05-14),

13. 11926843 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2024-03-12),

14. 11859181 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2024-01-02),

15. 11162114 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2021-11-02),

Title: Tyson D Bowen: Innovator in Genetic Engineering

Introduction

Tyson D Bowen is a prominent inventor based in Morrisville, NC (US). He has made significant contributions to the field of genetic engineering, particularly in the development of DNA modifying enzymes and related technologies. With a total of 15 patents to his name, Bowen's work is at the forefront of innovative solutions in biotechnology.

Latest Patents

Bowen's latest patents include groundbreaking inventions such as DNA modifying enzymes and active fragments and variants thereof, along with methods of use. His compositions and methods comprise novel deaminase polypeptides for targeted editing of nucleic acids. These compositions include fusion proteins that combine a DNA-binding polypeptide with a deaminase, which can be further integrated with RNA-guided nucleases and guide RNAs. Additionally, his work encompasses RNA-guided nucleases and active fragments that are designed for binding to target sequences, enabling the cleaving or modification of these sequences. The compositions also facilitate the visualization of target sequences and the modification of gene expression.

Career Highlights

Tyson D Bowen is currently associated with Lifeedit Therapeutics, Inc., where he continues to push the boundaries of genetic research and innovation. His expertise in the field has led to numerous advancements that are shaping the future of genetic therapies.

Collaborations

Bowen collaborates with notable professionals in the industry, including Alexandra Briner Crawley and Tedd D Elich. These partnerships enhance the scope and impact of his research, fostering a collaborative environment for innovation.

Conclusion

Tyson D Bowen is a key figure in the realm of genetic engineering, with a strong portfolio of patents that reflect his innovative spirit and dedication to advancing biotechnology. His contributions are paving the way for future developments in the field.

Profile summary based on public USPTO records.